Company attributes
Other attributes
Beximco Pharma was founded in 1976 and started operations in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of United States. Today Beximco Pharma manufactures and markets its own branded generics for several diseases including AIDS, cancer, asthma, hypertension, and diabetes for both national and international markets. It was the first drug company from Bangladesh to sell its products in the US.
In May 2020, the company introduced the world's first generic remdesivir for COVID-19 treatment. Beximco Pharma became the first company to obtain production and marketing authorization for Molnupiravir, the first and only specific oral anti covid drug in Bangladesh along with Eskayef Pharmaceuticals. Beximco Pharma's branded generic version of molnupiravir is being marketed as Emorivir.
